CALGARY, AB,
April 29, 2022 /CNW/ -
Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4)
("UI" or the "Company") a life sciences company with
a mission to develop and deliver medicalized ibogaine-centered
addiction care, advises that it has retained Mr. Shayne Nyquvest in a consulting role as Capital
Markets Advisor.
Mr. Nyquvest has extensive capital markets experience, with over
40 years involvement in aiding companies strategic fund-raising
activities, in the mining, cannabis and other emerging
industries. He served as the former Executive Vice-President
of investment banking firm Mackie Research Capital (where he worked
from June 2015 to July 2018) and a was founding member of Canaccord
Genuity Group, where he worked as a Senior Investment Advisor from
1993 to 2013.
Mr. Nyquvest co-founded UI in early 2018, after personally
seeing the transformational effects and potential of ibogaine and
was involved in UI's early-stage development until mid-2021.
His vision has been to see this innovative, plant-based treatment
adopted by the mainstream medical community as a solution to
helping break the opioid epidemic and other addictions.
Nick Karos, UI CEO noted "we are
pleased to have Shayne re-engaged in our strategic, business
development goals. He has an extensive network in the
investment community and was instrumental in UI's early-stage
financing and research activities. We continue to advance our
planned Health Canada clinical trials application for the use of
ibogaine in opioid use disorder and expect to provide additional
updates on this in the near future."
About Universal Ibogaine Inc.
UI is a life sciences company, with a mission to demonstrate the
safety and efficacy of its ibogaine based drug detox protocol
through a planned Canadian Clinical Trial (focused on opioid use
disorder), and ultimately to utilize that protocol around the globe
through planned future licensing agreements. UI is
concurrently developing a state of the art holistic addiction
treatment protocol at its Kelburn Recovery Centre that, when paired
with the planned ibogaine detox protocol, is intended to
revolutionize the way we treat addiction and drastically improve
the lives of individuals and families affected by
addiction.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
STATEMENTS
This news release may contain forward-looking statements and
information. Forward-looking information is frequently
characterized by words such as "plans", "expect", "project",
"intend", "will", "believe", "anticipate", "estimate", "scheduled",
"potential", or other similar words, or statements that certain
events or conditions "may", "should" or "could" occur. The
forward-looking statements and information are based on certain key
expectations and assumptions made by UI. Although UI
believes that the expectations and assumptions on which the
forward-looking statements are based are reasonable, undue
reliance should not be placed on the forward-looking statements
because UI can give no assurance that they will prove to be
correct.
Since forward-looking statements address future events and
conditions, by their very nature they involve inherent risks and
uncertainties. Actual results could differ materially from those
currently anticipated due to a number of factors and risks, which
include, but are not limited to, risks that required regulatory
approvals are not obtained. The reader is cautioned that
assumptions used in the preparation of such information, although
considered reasonable by UI at the time of preparation, may prove
to be incorrect and readers are cautioned not to place undue
reliance on forward-looking information, which speaks only to
conditions as of the date hereof. UI does not undertake any
obligation to release publicly any revisions to forward-looking
information contained herein to reflect events or circumstances
that occur after the date hereof or to reflect the occurrence of
unanticipated events, except as may be required under applicable
securities laws.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/universal-ibogaine-retains-shayne-nyquvest-as-capital-markets-advisor-301536451.html
SOURCE Universal Ibogaine Inc.
